ABMT (Advanced BioMedical Technologies) Total Equity: $-8.18 Mil (As of Jul. 2021)


What is Advanced BioMedical Technologies Total Equity?

Advanced BioMedical Technologies ABMT Total Equity is $-8.18 Mil as of Jul. 2021.

Advanced BioMedical Technologies's total equity for the quarter that ended in Jul. 2021 was $-8.18 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Advanced BioMedical Technologies Total Equity Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Total Equity Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.36 -5.00 -5.62 -6.48 -7.40

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.99 -7.40 -7.83 -7.97 -8.18

Advanced BioMedical Technologies Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Advanced BioMedical Technologies's Total Equity for the fiscal year that ended in Oct. 2020 is calculated as

Total Equity=Total Assets(Q: Oct. 2020 )-Total Liabilities(Q: Oct. 2020 )
=0.469-7.871
=-7.40

Advanced BioMedical Technologies's Total Equity for the quarter that ended in Jul. 2021 is calculated as

Total Equity=Total Assets(Q: Jul. 2021 )-Total Liabilities(Q: Jul. 2021 )
=0.397-8.579
=-8.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-8.18 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Total Equity of $-8.18 Mil as of Jul. 2021. The total amount of equity as record on a company's balance sheet. View historical data for Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Total Equity too high?
Advanced BioMedical Technologies' current Total Equity is $-8.18 Mil.
How does Advanced BioMedical Technologies' Total Equity compare to VYCO and ADMT?
Advanced BioMedical Technologies' Total Equity of $-8.18 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Total Equity is $-8.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Total Equity of $-8.18 Mil. The current Total Equity is $-8.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Total Equity is $-8.18 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.